The following posters were accepted for presentation at the 2021 uroLogic Conference held October 28-31 in St. Louis, MO.

Research

The Use of an External Urinary Incontinence Device to Prevent Incontinence Associated Dermatitis (IAD)
Frantz Dorestant, Jr., MSN, RN, CWOCN

A Comparative Analysis of Patients' Perceived Pain versus Actual Pain
Jennifer Lewis, DNP, APRN-CNP and Glenn Sulley, BSN, RN

Non-Research

Implementation of a Standardized Care Pathway for Ureteral Stents Patients across the Continuum of the Acute and Ambulatory Setting: A Quality Improvement Project
Ibukunoluwa Afolabi, DNP, FNP-BC

Implementation of an Enhanced Recovery after Surgery Protocol for Cystectomy Surgeries: A Quality Improvement Project
Weruche Agube, FNP, CUNP

Innovative Staffing Model in an Ambulatory Urology Clinic
Christine Allory, MSN, APRN, AGCNS-BC CURN; Sally Snediger, MSN, RN, CENP; Laura Spitaleri, MSN, RN, CNM; Ashley Tenison, MSN, RN, CMSRN

Industry

Effects of Once-Daily Vibegron 75 mg on Ambulatory Blood Pressure in Patients with Overactive Bladder: Results from a Double-Blind Study
Cornelia Haag-Molkenteller, MD, PhD; Michael Weber, MD; William White, MD; Diane Newman, DNP, ANP-BC; Jennifer King, PharmD, Ann Walker, MS, Paul Mudd, Jr., PharmD, MBA

Implications of Prostate-Specific Antigen Levels in Patients with Nonmetastatic Castration-Resistant and Metastatic Castration-Sensitive Prostate Cancer Treated with Enzalutamide
Tamara Huebner, MSN, RN, AGPCNP-BC; Monique Williams; Maha Hussain, Cora Sternberg, Neal Shore, Free Saad, Arnulf Stenzl, Betty Thompson, Andrew Armstrong

ConCaRe™: Continence Care Registry: Working to Understand ISC Practices and Your Patients Over Time
Diane Newman, DNP, ANP-BC, FAAN, BCB-PMD; Barbara Kearns, RGN, BA(Hons), DipHE, DipPM

Identifying Nurse Navigator Impact on Utilization of OnabotulinumtoxinA as Third Line Treatment in Overactive Bladder: A Retrospective Database Study
Diane Newman, DNP, ANP-BC, FAAN; Jennifer Miles-Thomas, Raveen Syan, Nitya Abraham, Keely Madaj, Krystal Anson Spenta, Amin Boroujerdi, Zane Bai, Lei Luo, Ekene Enemchukwu

Vibegron for the Treatment of Patients with Dry Overactive Bladder: A Subgroup Analysis from the EMPOWUR Trial
Diane Newman, DNP, ANP-BC, FAAN; David Staskin, MD; Jeffrey Frankel, MD; Susann Varano, MD; Matt Rosenberg, MD; Michael Kennelly, MD; Denise Shortino, MS; Rachael Jankowich, MSN, RN; Paul Mudd Jr, PharmD, MBA

Vibegron Shows Meaningful Changes in Clinical Endpoints in Patients with Overactive Bladder: Analyses From EMPOWUR
Diane Newman, DNP, ANP-BC, FAAN; Jeffrey Frankel, MD; David Staskin, MD; Susann Varano, MD; Matt Rosenberg, MD; Michael Kennelly, MD; Cynthia Girman, DrPH, FISPE; Denise Shortino, MS; Rachael A. Jankowich, MSN, RN; Paul Mudd, Jr., PharmD, MBA

6-Month LHRH Formulations Are a Good Choice During the COVID-19 Pandemic
Jennifer Sutton, BS, RN, CCRC; Rebecca Floyd, RN, CCRC; Stuart Atkinson, MB, ChB; Deborah Boldt-Houle, PhD